[1] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南. 实用肝脏病杂志,2006,9(6):321-324. [2] Marik PE,Gayowski T,Starzl TE,et a1.The hepatoadrenal syndrome:a common yet unrecognized clinical condition.Crit Care Med,2005,33:1254-1259. [3] Gao L,Wang JF,Xiang M,et a1.Expression of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure.Dig Dis Sci,201l,56:2605-2612. [4] Marik PE.Critical illness-related corticosteroid insufficiency.Chest,2009.135:181-193. [5] 顾锡炳,徐月琴.重型肝炎血清皮质醇浓度与病情及预后的关系.肝脏,2006,1(3):212-213. [6] Fujiwara K,Yasui S,Yonemitsu Y,et al.Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.J Gastroenterol,2008,43(9):711-719. [7] 陈从新,郭顺明,刘波,等.糖皮质激素阻断慢性乙型肝炎肝衰竭发生的临床对照观察.中华肝脏病杂志,2003,11:37-40. [8] 吴锦瑜,黎明,张华.糖皮质激素对早期肝衰竭患者转归的影响.南方医科大学学报,2011,31(3):554-556. [9] 骆抗先.乙型肝炎基础和临床.3版. 北京:人民卫生出版社,2006:702. [10] 李梦东.实用传染病学. 2版. 北京:人民卫生出版社,1998:104-126. [11] Fujiwara K,Yasui S,Okitsu K,et al.The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.J Gastroenterol,2010,45(12):1255-1262. |